Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.

Drug Resistance and the Solid Tumor Microenvironment

Tredan, O., Galmarini, C. M., Patel, K., Tannock, I. F. · 2007 · JNCI Journal of the National Cancer Institute

Abstract

Resistance of human tumors to anticancer drugs is most often ascribed to gene mutations, gene amplification, or epigenetic changes that influence the uptake, metabolism, or export of drugs from single cells. Another important yet little-appreciated cause of anticancer drug resistance is the limited ability of drugs to penetrate tumor tissue and to reach all of the tumor cells in a potentially lethal concentration. To reach all viable cells in the tumor, anticancer drugs must be delivered efficiently through the tumor vasculature, cross the vessel wall, and traverse the tumor tissue. In addition, heterogeneity within the tumor microenvironment leads to marked gradients in the rate of cell proliferation and to regions of hypoxia and acidity, all of which can influence the sensitivity of the tumor cells to drug treatment. In this review, we describe how the tumor microenvironment may be involved in the resistance of solid tumors to chemotherapy and discuss potential strategies to improve the effectiveness of drug treatment by modifying factors relating to the tumor microenvironment.

Overview

Integrity signals

Registry

Crossref · 10.1093/jnci/djm135

Cites

186 of 186 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 185 references

Research works printed but not linked: 44

  1. Teicher, 1990, Science, 247, 1457, 10.1126/science.2108497 · doi:10.1126/science.2108497 · Paper page
  2. Brekken, 2000, Anticancer Research, 20, 3503
  3. Netti, 2000, Cancer Research, 60, 2497
  4. Durand, 1986, JNCI Journal of the National Cancer Institute, 77, 247
  5. Jain, 1988, Cancer Research, 48, 2641
  6. Sevick, 1989, Cancer Research, 49, 3506
  7. Sevick, 1991, Cancer Research, 51, 2727
  8. Tannock, 1989, Cancer Research, 49, 4373
  9. Leu, 2000, Cancer Research, 60, 4324
  10. Milosevic, 1998, Cancer, 82, 2418, 10.1002/(SICI)1097-0142(19980615)82:12<2418::AID-CNCR16>3.0.CO;2-S · DOI
  11. Stohrer, 2000, Cancer Research, 60, 4251
  12. Evans, 2000, Cancer Research, 60, 2018
  13. Vaupel, 1989, Cancer Research, 49, 6449
  14. Tannock, 1978, Cancer treatment reports, 62, 1117
  15. Guo, 1998, Journal of cellular physiology, 175, 141, 10.1002/(SICI)1097-4652(199805)175:2<141::AID-JCP3>3.0.CO;2-O · doi:10.1002/(sici)1097-4652(199805)175:2<141::aid-jcp3>3.0.co;2-o
  16. Kinoshita, 2001, International journal of cancer. Journal international du cancer, 91, 322, 10.1002/1097-0215(200002)9999:9999<::AID-IJC1064>3.0.CO;2-P · doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1064>3.0.co;2-p
  17. Kondo, 2001, Cancer Research, 61, 7603
  18. Comerford, 2002, Cancer Research, 62, 3387
  19. Yun, 1995, Oncology research, 7, 583
  20. Ledoux, 2003, Cancer Research, 63, 7284
  21. Kennedy, 1987, Anti-cancer drug design, 2, 181
  22. Jain, 1990, Cancer Research, 50, 814s
  23. Netti, 1995, Cancer Research, 55, 5451
  24. Curti, 1993, Cancer Research, 53, 2204
  25. Boucher, 1990, Cancer Research, 50, 4478
  26. Fujimori, 1990, Journal of Nuclear Medicine, 31, 1191
  27. Juweid, 1992, Cancer Research, 52, 5144
  28. West, 1980, Cancer Research, 40, 3665
  29. Tannock, 2002, Clinical Cancer Research, 8, 878
  30. Lankelma, 1999, Clinical Cancer Research, 5, 1703
  31. Miyamoto, 2005, Oncology reports, 14, 1421
  32. Winkler, 2004, Cancer cell, 6, 553
  33. 2006, Cancer Research, 24, 11520
  34. Kristjansen, 1993, Cancer Research, 53, 4764
  35. Griffon-Etienne, 1999, Cancer Research, 59, 3776
  36. Rubin, 2000, International journal of cancer. Journal international du cancer, 86, 636, 10.1002/(SICI)1097-0215(20000601)86:5<636::AID-IJC6>3.0.CO;2-R · DOI
  37. Pietras, 2002, Cancer Research, 62, 5476
  38. Pietras, 2003, Clinical Cancer Research, 9, 3779
  39. Tunggal, 2000, International journal of cancer. Journal international du cancer, 86, 101, 10.1002/(SICI)1097-0215(20000401)86:1<101::AID-IJC16>3.0.CO;2-I · DOI
  40. Dalton, 1995, Cancer, 75, 815, 10.1002/1097-0142(19950201)75:3<815::AID-CNCR2820750311>3.0.CO;2-R · DOI
  41. Kozin, 2001, Cancer Research, 61, 4740
  42. Kontermann, 2006, Current opinion in molecular therapeutics, 8, 39
  43. Hicks, 2003, Cancer Research, 63, 5970
  44. Mose, 1964, Cancer Research, 24, 212

Cited by

See all 2,116

Metadata

Authors
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F.
Affiliations
Lyon 1 Université (FR)
Venue
JNCI Journal of the National Cancer Institute
Published
2007-09-25
Volume
99
Issue
19
Pages
1441-1454
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2165836181
Cited by
2,116
References
185
Citations by year
2026: 56 · 2025: 69 · 2024: 98 · 2023: 129 · 2022: 138 · 2021: 176 · 2020: 173 · 2019: 153 · 2018: 149 · 2017: 150 · 2016: 151 · 2015: 140 · 2014: 130 · 2013: 103 · 2012: 90
FWCI
4.39
Type
journal article
Language
en
Open access
closed
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
drug resistance, solid tumors, tumor microenvironment, chemoresistance, tumor heterogeneity, tumor hypoxia, tumor acidosis, drug penetration, tumor vasculature, drug delivery
MeSH terms
Animals, Antineoplastic Agents, Humans, Microcirculation, Neoplasms, Cell Hypoxia, Drug Resistance, Neoplasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug Resistance and the Solid Tumor Microenvironment. https://app.cochat.ai/papers/10.1093/jnci/djm135
The paper
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007). Drug Resistance and the Solid Tumor Microenvironment. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djm135

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.